Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Friede

Showing results (351-360 of 393) with videos related to

Pageof 40
Sort By:
Multiple Sclerosis and Related Disorders|November 24, 2023
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 24, 2023
Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancerMarkus S Anker, Alessia Lena, Eric J Roeland, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|January 17, 2025
Rationale and design of the HERZCHECK trial: Detection of early heart failure using telemedicine and cardiovascular magnetic resonance in structurally weak regions (NCT05122793)Sebastian Kelle, Anna Clara Nolden, Maximilian Leo Müller, et al.
Brain : a Journal of Neurology|October 8, 2021
The impact of smoking cessation on multiple sclerosis disease progressionJeff Rodgers, Tim Friede, Frederick W Vonberg, et al.
Kidney International|December 15, 2011
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancyOliver Gross, Christoph Licht, Hans J Anders, et al.
Kidney International Reports|December 19, 2024
SGLT2-Inhibition in Patients With Alport SyndromeJan Boeckhaus, Daniel P Gale, James Simon, et al.
The New England Journal of Medicine|March 18, 2026
Left Atrial Appendage Closure or Medical Therapy in Atrial FibrillationUlf Landmesser, Carsten Skurk, Paulus Kirchhof, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 11, 2017
Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countriesChristian Sticherling, Barbora Arendacka, Jesper Hastrup Svendsen, et al.
BMJ Open|December 2, 2020
Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trialChristian Otte, Woo Ri Chae, Jan Nowacki, et al.
European Heart Journal|August 26, 2022
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac deathKatja Zeppenfeld, Jacob Tfelt-Hansen, Marta de Riva, et al.
Pageof 40

Showing results (351-360 of 393) with videos related to

Sort By:
Pageof 40
Multiple Sclerosis and Related Disorders|November 24, 2023
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 24, 2023
Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancerMarkus S Anker, Alessia Lena, Eric J Roeland, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|January 17, 2025
Rationale and design of the HERZCHECK trial: Detection of early heart failure using telemedicine and cardiovascular magnetic resonance in structurally weak regions (NCT05122793)Sebastian Kelle, Anna Clara Nolden, Maximilian Leo Müller, et al.
Brain : a Journal of Neurology|October 8, 2021
The impact of smoking cessation on multiple sclerosis disease progressionJeff Rodgers, Tim Friede, Frederick W Vonberg, et al.
Kidney International|December 15, 2011
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancyOliver Gross, Christoph Licht, Hans J Anders, et al.
Kidney International Reports|December 19, 2024
SGLT2-Inhibition in Patients With Alport SyndromeJan Boeckhaus, Daniel P Gale, James Simon, et al.
The New England Journal of Medicine|March 18, 2026
Left Atrial Appendage Closure or Medical Therapy in Atrial FibrillationUlf Landmesser, Carsten Skurk, Paulus Kirchhof, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 11, 2017
Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countriesChristian Sticherling, Barbora Arendacka, Jesper Hastrup Svendsen, et al.
BMJ Open|December 2, 2020
Simvastatin add-on to escitalopram in patients with comorbid obesity and major depression (SIMCODE): study protocol of a multicentre, randomised, double-blind, placebo-controlled trialChristian Otte, Woo Ri Chae, Jan Nowacki, et al.
European Heart Journal|August 26, 2022
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac deathKatja Zeppenfeld, Jacob Tfelt-Hansen, Marta de Riva, et al.
Pageof 40